These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9400355)

  • 1. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
    Tilley BC; Lyden PD; Brott TG; Lu M; Levine SR; Welch KM
    Arch Neurol; 1997 Dec; 54(12):1466-74. PubMed ID: 9400355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
    Stroke; 1997 Aug; 28(8):1530-40. PubMed ID: 9259745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
    Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
    Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Code Stroke: rapid transport, triage and treatment using rt-PA therapy. The NINDS rt-PA Stroke Study Group.
    Rapp K; Bratina P; Barch C; Braimah J; Daley S; Donnarumma R; Kongable G; Sailor S; Spilker J
    J Neurosci Nurs; 1997 Dec; 29(6):361-6. PubMed ID: 9479657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability?
    Wyer PC; Osborn HH
    Ann Emerg Med; 1997 Nov; 30(5):629-38. PubMed ID: 9360575
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
    Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV
    Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Logistics in acute stroke management.
    Broderick JP
    Drugs; 1997; 54 Suppl 3():109-16; discussion 116-7. PubMed ID: 9360858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis.
    Smith RW; Scott PA; Grant RJ; Chudnofsky CR; Frederiksen SM
    Acad Emerg Med; 1999 Jun; 6(6):618-25. PubMed ID: 10386679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study.
    Kleindorfer D; Kissela B; Schneider A; Woo D; Khoury J; Miller R; Alwell K; Gebel J; Szaflarski J; Pancioli A; Jauch E; Moomaw C; Shukla R; Broderick JP;
    Stroke; 2004 Feb; 35(2):e27-9. PubMed ID: 14739423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview: hyperacute rt-PA stroke treatment. The NINDS rt-PA Stroke Study Group.
    Donnarumma R; Kongable G; Barch C; Braimah J; Bratina P; Daley S; Rapp K; Sailor S; Spilker J
    J Neurosci Nurs; 1997 Dec; 29(6):351-5. PubMed ID: 9479655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.
    Patel SC; Levine SR; Tilley BC; Grotta JC; Lu M; Frankel M; Haley EC; Brott TG; Broderick JP; Horowitz S; Lyden PD; Lewandowski CA; Marler JR; Welch KM;
    JAMA; 2001 Dec; 286(22):2830-8. PubMed ID: 11735758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperacute stroke therapy with tissue plasminogen activator.
    Alberts MJ
    Am J Cardiol; 1997 Aug; 80(4C):29D-34D; discussion 35D-39D. PubMed ID: 9284041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial.
    Tilley BC; Marler J; Geller NL; Lu M; Legler J; Brott T; Lyden P; Grotta J
    Stroke; 1996 Nov; 27(11):2136-42. PubMed ID: 8898828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.
    Tampieri A; Giovannini E; Rusconi AM; Cristoni L; Bendanti D; Cenni P; Lenzi T
    Intern Emerg Med; 2015 Mar; 10(2):181-92. PubMed ID: 25430677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current emergency department management of stroke in Houston, Texas.
    Bratina P; Greenberg L; Pasteur W; Grotta JC
    Stroke; 1995 Mar; 26(3):409-14. PubMed ID: 7886715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.
    Fagan SC; Morgenstern LB; Petitta A; Ward RE; Tilley BC; Marler JR; Levine SR; Broderick JP; Kwiatkowski TG; Frankel M; Brott TG; Walker MD
    Neurology; 1998 Apr; 50(4):883-90. PubMed ID: 9566367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.